July 23, 2026
Backed by results from the OPTIMA trial, the Prosigna Breast Risk of Recurrence (ROR) test offers a new way to personalize treatment and reduce unnecessary chemotherapy for patients with breast cancer.
May 20, 2026
The genetic tool allows doctors to better tailor treatments to each patient's unique subtype of B-cell acute lymphoblastic leukemia.
February 2, 2026
Researchers at the UNC School of Medicine have developed a tool that can identify airway mucus abnormalities in patients with chronic bronchitis, chronic obstructive pulmonary disease (COPD), or asthma before symptoms start.
May 23, 2025
Published in Blood, a new study led by UNC School of Medicine’s Alisa Wolberg, PhD, reveals that reducing or blocking the protein that causes blood clot breakdown does not increase the formation of dangerous clots known as thromboses.
June 12, 2024
William Woodard “Bill” McLendon, MD, Professor Emeritus and Vice Chair of Pathology and Laboratory Medicine, former Director of the Department of Hospital Laboratories, UNC Hospitals, passed away at age 93.
August 6, 2020
Silvio Antoniak, PhD, assistant professor in the UNC Department of Pathology and Laboratory Medicine and member of the UNC Blood Research Center and the UNC McAllister Heart Institute, was awarded a four-year, $2.2 million grant from the NIH-NHLBI to investigate the potential therapeutic approach in inhibiting PAR1 to treat chemotherapy-induced heart failure.
August 6, 2020
Michelle Campbell (’18 MS MDS), Sophia Chandrasekar ’16 and Letycia Nuñez-Argote ’07, each received recognition for their contributions to the profession.
June 11, 2020
The UNC School of Medicine and NC TraCS awarded pilot funding to three teams for the 2020 Emerging Challenges in Biomedical Research Awards in a call highlighting research to address the COVID-19 pandemic